molecule kinase inhibitors Search Results


90
Inserm Transfert ikk2 inhibitor - as602868
Ikk2 Inhibitor As602868, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ikk2 inhibitor - as602868/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
ikk2 inhibitor - as602868 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Mirae Biotech Co Ltd small-molecule kinase inhibitors and protein degraders
Small Molecule Kinase Inhibitors And Protein Degraders, supplied by Mirae Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small-molecule kinase inhibitors and protein degraders/product/Mirae Biotech Co Ltd
Average 90 stars, based on 1 article reviews
small-molecule kinase inhibitors and protein degraders - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Exonate Ltd small molecule inhibitor targeting serine/arginine-rich protein-specific kinase 1
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Small Molecule Inhibitor Targeting Serine/Arginine Rich Protein Specific Kinase 1, supplied by Exonate Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule inhibitor targeting serine/arginine-rich protein-specific kinase 1/product/Exonate Ltd
Average 90 stars, based on 1 article reviews
small molecule inhibitor targeting serine/arginine-rich protein-specific kinase 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Janssen atp-competitive small molecule tyrosine kinase inhibitor against fgfr1-4 jnj-42756493
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Atp Competitive Small Molecule Tyrosine Kinase Inhibitor Against Fgfr1 4 Jnj 42756493, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atp-competitive small molecule tyrosine kinase inhibitor against fgfr1-4 jnj-42756493/product/Janssen
Average 90 stars, based on 1 article reviews
atp-competitive small molecule tyrosine kinase inhibitor against fgfr1-4 jnj-42756493 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novartis small molecule tyrosine kinase inhibitor, imatinib mesylate st12571
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Small Molecule Tyrosine Kinase Inhibitor, Imatinib Mesylate St12571, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule tyrosine kinase inhibitor, imatinib mesylate st12571/product/Novartis
Average 90 stars, based on 1 article reviews
small molecule tyrosine kinase inhibitor, imatinib mesylate st12571 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd small molecule inhibitors of the anticancer target protein kinase b (also known as akt)
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Small Molecule Inhibitors Of The Anticancer Target Protein Kinase B (Also Known As Akt), supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule inhibitors of the anticancer target protein kinase b (also known as akt)/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
small molecule inhibitors of the anticancer target protein kinase b (also known as akt) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AbMole Bioscience plx-4720
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Plx 4720, supplied by AbMole Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plx-4720/product/AbMole Bioscience
Average 90 stars, based on 1 article reviews
plx-4720 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Pfizer Inc small molecule receptor tyrosine kinase inhibitor
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Small Molecule Receptor Tyrosine Kinase Inhibitor, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule receptor tyrosine kinase inhibitor/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
small molecule receptor tyrosine kinase inhibitor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BeiGene Inc small-molecule bruton’s tyrosine kinase inhibitor zanubrutinib
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Small Molecule Bruton’s Tyrosine Kinase Inhibitor Zanubrutinib, supplied by BeiGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small-molecule bruton’s tyrosine kinase inhibitor zanubrutinib/product/BeiGene Inc
Average 90 stars, based on 1 article reviews
small-molecule bruton’s tyrosine kinase inhibitor zanubrutinib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Glaxo Smith 367 small-molecule kinase inhibitors
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
367 Small Molecule Kinase Inhibitors, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/367 small-molecule kinase inhibitors/product/Glaxo Smith
Average 90 stars, based on 1 article reviews
367 small-molecule kinase inhibitors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Glaxo Smith small-molecule atp-competitive kinase inhibitors
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Small Molecule Atp Competitive Kinase Inhibitors, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small-molecule atp-competitive kinase inhibitors/product/Glaxo Smith
Average 90 stars, based on 1 article reviews
small-molecule atp-competitive kinase inhibitors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Array BioPharma arry-954
Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019
Arry 954, supplied by Array BioPharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arry-954/product/Array BioPharma
Average 90 stars, based on 1 article reviews
arry-954 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019

Journal: Investigative Ophthalmology & Visual Science

Article Title: The Landscape of Vascular Endothelial Growth Factor Inhibition in Retinal Diseases

doi: 10.1167/iovs.66.1.47

Figure Lengend Snippet: Novel VEGF-Targeting Therapeutics in Clinical Development for Neovascular AMD or Diabetic Macular Edema Since September 2019

Article Snippet: Serine/arginine-rich protein-specific kinase 1 , EXN407 , Exonate , Small molecule inhibitor targeting serine/arginine-rich protein-specific kinase 1 , Topical , Phases I and II(NCT04565756).

Techniques: Formulation